Alendronate Sodium Tablets

06 June 2005

Reason for the Shortage

Merck is making the 40-mg tablets, indicated for once-a-day use by patients with Paget's disease, available only through the Merck Paget's Patient Support Program, administered by Pharmacare. The 40-mg tablets are not being shipped to wholesalers, hospitals, or pharmacies.

Estimated Resupply Dates

Merck is making the 40-mg tablets, indicated for once-a-day use by patients with Paget's disease, available only through the Merck Paget's Patient Support Program, administered by Pharmacare. The 40-mg tablets are not being shipped to wholesalers, hospitals, or pharmacies.

Related Shortages

• Colchicine Injection— No Longer Available
• Colchicine Tablets
• Cyclosporine Injection— Resolved
• Dexrazoxane Injection
• Isosulfan Blue Injection— Resolved
• Leucovorin Injection— Resolved
• Methylene Blue Injection— Resolved
• Metyrosine Capsules— Resolved
• Muromonab-CD3 Solution for Injection— Resolved
• Pralidoxime Chloride Injection— Resolved
• Pralidoxime Injection— Resolved
• Sodium Fluoride Chewable Tablets

Updated

June 6, 2006, July 22, 2005, University of Utah, Drug Information Service

Back to Drug Shortage Product Bulletins